Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'carmoxirole hydrochloride'

Search results for: 'carmoxirole hydrochloride'

Items 41-50 of 58

Page
per page
  1. TC-A 2317 hydrochloride
    A4489 TC-A 2317 hydrochloride
    Target: Aurora Kinases
    Summary: Aurora kinase A inhibitor,potent and selective
      <39.29 mg/mL
  2. Tropisetron Hydrochloride
    B2258 Tropisetron Hydrochloride
    Target: 5-HT3 Receptors
    Summary: 5-HT3 receptor antagonist
      ≥28.4 mg/mL
  3. Berberine
    N1368 Berberine
      insoluble in H2O; insoluble in EtOH; ≥14.95 mg/mL
  4. Tubastatin A HCl
    A8547 Tubastatin A HCl
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent and selective
      insoluble in EtOH; ≥12.34 mg/mL
  5. SRT1720 HCl
    A4180 SRT1720 HCl
     3 Citation
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1 activator
      ≥25.3 mg/mL
  6. Thiamine HCl (Vitamin B1)
    B1852 Thiamine HCl (Vitamin B1)
    Summary: hydrochloride salt form of thiamine
      insoluble in EtOH; ≥10.9 mg/mL
  7. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  8. Tizanidine HCl
    B1368 Tizanidine HCl
    Summary: α2-adrenergic receptor agonist
      ≥14.51 mg/mL
  9. Ondansetron HCl
    A5166 Ondansetron HCl
    Target: 5-HT3 Receptors
    Summary: 5-HT3 receptor antagonist
      insoluble in EtOH; insoluble in H2O; ≥33.04 mg/mL
  10. Phenformin HCl
    B1373 Phenformin HCl
     1 Citation
    Target: AMPK
    Summary: biguanidine drug with anti-diabetic activity
      ≥12.1 mg/mL

Items 41-50 of 58

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 53item
  2. Natural Products 2item
  3. Lab Reagents 2item
Specificity
  1. Selective 31item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 2item
Target
  1. Cyclin-Dependent Kinases 2item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 1 item
  4. PI3K 1 item
  5. Raf 1 item
  6. Aurora Kinases 1 item
  7. EZH2 1 item
  8. mTOR 1 item
  9. Thymidine Phosphorylases 1 item
  10. VEGFR 1 item
  11. PDGFR 1 item
  12. c-Kit 1 item
  13. Phosphodiesterases (PDEs) 1 item
  14. Sir2-like Family Deacetylases (Sirtuins) 1 item
  15. Aminopeptidases 1 item
  16. EGFR 2item
  17. FAK 1 item
  18. Syk 1 item
  19. DNA-PK 1 item
  20. HSP90 1 item
  21. AMPK 1 item
  22. Topoisomerases 1 item
  23. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  24. Pyk2 1 item
  25. 5-HT2 Receptors 2item
  26. S1P receptors 1 item
  27. ALK 1 item
  28. Myosin light chain kinases (MLCKs) 1 item
  29. 5-HT3 Receptors 2item
  30. Squalene epoxidases 2item
  31. Nampt 1 item
  32. Glutamate (Metabotropic) Group I Receptors 1 item
  33. Histamine H1 Receptors 1 item
  34. Sigma Receptors 1 item
  35. AChE 1 item
  36. Inward Rectifier Potassium (Kir) Channels 1 item
  37. c-RET 1 item
  38. guanylyl cyclase 1 item
  39. dopamine receptor 1 item
  40. 5-HT1 Receptor 2item
  41. 5-HT2 Receptor 1 item
  42. NMPRTase 1 item
  43. IKK 1 item
  44. Antibiotic 1 item
  45. Calmodulins 1 item
  46. Calcium-Sensing Receptors (CaSRs) 2item
  47. PAR receptor 1 item
  48. TRPC channel 1 item
  49. GABAA receptor 1 item
  50. CRF1 Receptors 1 item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Bacterial Infectios 1 item
  3. Bladder Cancer 2item
  4. Breast Cancer 3item
  5. Cancer 18item
  6. Chronic Lymphocytic Leukemia 1 item
  7. Colon Cancer 2item
  8. Colorectal Cancer 2item
  9. Erectile Dysfunction 1 item
  10. Glioblastoma 2item
  11. Glioma 2item
  12. Hepatocellular Carcinoma 1 item
  13. Inflammatory Diseases 1 item
  14. Lung Cancer 2item
  15. Multidrug Resistance Studies 1 item
  16. Multiple Myeloma 2item
  17. Narcolepsy 1 item
  18. Non-small Cell Lung Cancer 1 item
  19. Pancreatic Cancer 2item
  20. Prostate Cancer 3item
  21. Schizophrenia 1 item
  22. Type 2 Diabetes 1 item